{
  "nctId": "NCT03303469",
  "briefTitle": "Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging",
  "officialTitle": "Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: [18F]Fluoromisonidazole (FMISO) Imaging",
  "protocolDocument": {
    "nctId": "NCT03303469",
    "filename": "Prot_SAP_001.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-07-30",
    "uploadDate": "2021-02-15T10:15",
    "size": 3777867,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT03303469/document/Prot_SAP_001.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "PHASE2"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "NA",
  "interventionModel": "SINGLE_GROUP",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 3,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2017-10-30",
    "completionDate": "2021-01-06",
    "primaryCompletionDate": "2021-01-06",
    "firstSubmitDate": "2017-09-13",
    "firstPostDate": "2017-10-06"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Adult (\\> 18 years of age) patients with documented HCC tumor mass \\>3cm, who are scheduled to undergo TACE with additional selective internal radiation therapy (SIRT)\n* The appropriate criteria for inclusion for this patient population are:\n* Biopsy or radiological diagnosis of HCC (defined as Organ Procurement and Transplantation Network (OPTN\\*) Category 5 lesion either on CT or MRI)\n* Scheduled for TACE (using doxorubicin-eluting beads) + SBRT\n* Willingness to undergo PET/CT\n* Able to lie on the imaging table for up to 1 hour.\n* Able to provide signed informed consent.\n* Women with childbearing potential must have a negative urine Beta-Human Chorionic Gonadotropin (Î²-hCG) test day of procedure\n\nExclusion Criteria:\n\n* Estimated life expectancy \\<12 months or serious medical co-morbidities that would preclude definitive local therapy\n* Unable to lie on the imaging table\n* Age less than 18 years.\n* Pregnancy or lactation\n* Inability or unwillingness to provide informed consent.\n* Weight \\>500 lbs (the weight limit of the tomograph gantry table)",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Quantitate HCC Tumor Hypoxia at Baseline Using FMISO Positron Emission Tomography (PET).",
        "description": "Perform PET/CT imaging using FMISO at baseline to measure tumor hypoxia",
        "timeFrame": "At baseline"
      },
      {
        "measure": "Measure Changes in HCC Tumor Hypoxia and Blood Flow After Trans-arterial Chemoembolization (TACE), Prior to Radiotherapy.",
        "description": "Perform PET/CT imaging using FMISO post-TACE and prior to Stereotactic body radiation therapy (SBRT) to determine tumor hypoxia",
        "timeFrame": "1 month post-TACE procedures and prior to SBRT"
      },
      {
        "measure": "Measure Changes in Treated HCC Tumor Hypoxia Following TACE and Radiotherapy",
        "description": "Perform PET/CT imaging using FMISO post-SBRT to determine tumor hypoxia",
        "timeFrame": "1 month post-SBRT"
      }
    ],
    "secondary": [],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 0,
      "otherCount": 0,
      "totalCount": 3
    },
    "studyDesign": {
      "phases": [
        "PHASE2"
      ],
      "isRandomized": false,
      "isMasked": false,
      "interventionModel": "SINGLE_GROUP"
    },
    "overallComplexityScore": 34,
    "complexityCategory": "Moderate"
  },
  "collectionDate": "2025-09-22T02:30:55.469Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}